OMBITASVIR/PARITAPREVIR/RITONAVIR FOR TREATMENT OF HCV GENOTYPE 1B IN JAPANESE PATIENTS WITH OR WITHOUT CIRRHOSIS: RESULTS FROM GIFT-I
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
K Chayama, F Suzuki, K Ikeda, H Toyoda, K Sato, Y Karino, Y Matsuzaki, K Kioka, T Pilot-Matias, C Setze, X Zhang, P Badri, T Yanke, T Matsuda, RA Vilchez, L Rodrigues-Jr, H Kumada
